Healthcare providers need more than advanced imaging tools. They need solutions they can use with confidence in everyday clinical practice. That is why MDR certification for medical imaging software is becoming an important factor when choosing diagnostic technology.
The BRIGHTER Medical Imaging Platform and the CS GATED – Cardiac CT algorithm for automated coronary artery calcium scoring, developed by Graylight Imaging, have received MDR certification as Class IIa medical devices, confirming they meet European requirements for software used in healthcare settings.
For users, this means BRIGHTER is not only a powerful imaging platform but also a solution developed in accordance with recognized standards for safety, performance, and quality.
CE compliance is confirmed by an EU Quality Management System Certificate in accordance with Annex IX Chapters I and III of Regulation (EU) 2017/745 (MDR). The certification covered two areas:
More specifically, these two areas refer to two products:
The independent notified body TÜV Nord carried out the certification process and confirmed that both our quality management system and the products’ technical documentation comply with the MDR requirements. The process took over a year.
The certificate, issued under Regulation (EU) 2017/745, confirms that a medical device meets stringent safety and performance requirements. It also allows the product to bear the CE mark and be lawfully placed on the market across the European Union.
Under Article 52 of the MDR, every medical device must undergo a conformity assessment before being placed on the market. This assessment covers, among other things, the general safety and performance requirements, including complete technical documentation and risk management throughout the device’s life cycle [1].
"For a platform that enables the review and analysis of medical images while also supporting the assessment of coronary artery calcifications, MDR certification is the foundation for bringing a medical device to market. It confirms that BRIGHTER is a platform that meets the quality requirements set for technologies intended for healthcare."
Marek Pitura, Head of Project Management at Graylight Imaging.
Before a company receives the certificate, it must complete the entire certification process under the MDR (Regulation (EU) 2017/745).
The process assesses, among other things, the quality management system, risk management, and the device’s technical documentation. This is why developing a medical product requires rigorous adherence to procedures and close collaboration among team members.
“The most important aspect of creating and developing a medical device is the discipline required of the team. It means exercising exceptional care at every stage: when introducing changes to the system, developing new features, and releasing new versions.
Every move must be carefully analyzed for risk and its impact on future product performance. Our users are physicians. They are the ones who will work with the technology we build. We have to respect their work and, in turn, deliver a solution that brings real value to their daily duties. After all, you cannot experiment on the user. We must provide them with a product that is reliable, functional, responsive to their needs, and safe.
Risk analysis, appropriate quality, technical documentation, and full traceability of the processes behind medical product development are integral to the team’s work. That’s why we work together on every task from start to finish, analyzing risks and the next steps of development.
Standards, norms, and regulations don’t have to hold back innovation. Our goal was to create a product development process in which engineers can experiment and solve problems while building, from the very beginning, a product that is usable, tested, validated, and ready for safe use. In our project, nobody works in isolation. We act as one team, taking responsibility for everything we create, for the product as a whole."Michał Krywalski, Delivery Manager at Graylight Imaging.
When choosing medical imaging software, healthcare organizations look for solutions that meet recognized regulatory requirements. An MDR-compliant platform and an AI-based algorithm provide additional assurance that the software has been developed, maintained, and monitored in line with established quality and safety standards. For healthcare professionals, this means trust in the technology underpinning their daily diagnostic work.
The BRIGHTER platform’s MDR compliance marks an important milestone in its ongoing development.
As medical imaging continues to evolve, our goal remains unchanged: to deliver innovative, clinically relevant solutions that support healthcare professionals. We are focusing on cardiology by developing new algorithms for cardiac analysis, and we will strive to obtain certification for these algorithms in the future.
What is an MDR (Medical Device Regulation) certificate?
It is a document confirming compliance with the MDR, Regulation (EU) 2017/745 of the European Parliament and of the Council. The regulation sets out the requirements a medical device must meet before it can be placed on the EU market.
Which class of medical devices do the BRIGHTER platform and the Calcium Score algorithm belong to?
Both the BRIGHTER platform and the Calcium Score algorithm are Class IIa medical devices.
What does it mean that the BRIGHTER platform and the Calcium Score algorithm are Class IIa medical devices?
Under Regulation (EU) 2017/745, medical devices fall into one of four risk classes: I, IIa, IIb, and III, ranging from the lowest to the highest level of risk associated with their use.
The class a device is assigned to depends on the level of risk its use poses to patients or users. Class IIa covers medical devices with a moderate (medium) level of risk.
Who issues the MDR certificate?
A notified body, an independent organization designated to assess the conformity of medical devices, issues the certificate. In Graylight Imaging’s case, TÜV Nord issued it. Before receiving the certificate, a company must complete the full MDR certification process (Regulation (EU) 2017/745).
REFERENCES:
[1] [1] Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. ): https://eur-lex.europa.eu/legal-content/PL/TXT/PDF/?uri=CELEX:32017R0745